Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / The 4th China Intl Import Expo

    Top executives weigh in at CIIE

    chinadaily.com.cn | Updated: 2021-11-08 06:40
    Share
    Share - WeChat
    Chen Siyuan, president of Bristol Myers Squibb for Chinese mainland and Hong Kong. [Photo provided to chinadaily.com.cn]

    A1: This is our third year at the CIIE, and this year we are proudly bringing more of our breakthrough innovations and new strategic partnerships to show the world how the patient-centric innovation embedded into the DNA of BMS can help Chinese patients fight serious diseases, and help China achieve the goals of its Healthy China vision.

    China is a strategic and important market for BMS. The CIIE provides us with an excellent platform to catch vast and promising collaboration opportunities.

    A2: China is an important engine of the global economy and we see the critical role China will play in helping the global economy recover from the impact of COVID-19.

    We have seen in the past years the positive "carry-on effects" produced by the CIIE through promoting the economic development of China and the world.

    This year, for the very first time, the Biomedicine Subsection will gather global innovations while also driving focus on more collaborations for open innovation. And the establishment of the Biomedical Committee will bring more "carry-on effects" and a dynamic momentum to the global biomedical innovation.

    We would like to take advantage of the shared opportunities offered by the CIIE and the unique benefits of the Biomedical Committee to continue to work closely with the Chinese government and more local partners to support the development of "Healthy China 2030."

    A3: China is driving the global economic recovery through its effort to increase imports. Take the healthcare industry as an example. China has accelerated the review and approval process for global innovative medicines in recent years, which not only benefits Chinese patients but also provides new impetus for the development and innovation of the global health industry.

    BMS is making a long-term commitment to healthcare and innovation in China, as a key growth driver for BMS. In the next five years, our goal is to introduce in China up to 30 innovative medicines and indications from our diverse therapeutic areas. We are confident BMS will hit our goal with supportive Chinese government policy.

    A4: China has become a vibrant player in the rapidly growing biomedical industry. In particular, with the guidance of the "dual circulation" strategy, China's biomedical industry will play a critical role in collaboration for open innovation, and in contribution to the achievement of Healthy China 2030 plan and the 14th Five-Year Plan.

    China also has already become one of the top players globally in the contribution to pharmaceutical innovation.

    BMS is committed to working with the government to foster innovation and economic growth.

    A5: There is no doubt that China has been continuously improving its business environment and encouraging open innovation and collaboration. In healthcare, China has made significant progress in the last several years, expanding access to innovative medicines for its people, reforming its health system and elevating its regulations to meet international standards. Leveraging this, BMS has accelerated introduction of its innovative medicines to benefit patients in China. Our intended investment in China is also made with the growing supportive environment of the Chinese government. This makes me more confident in the future of our business in China.

    A7: Based on our long-term commitment to the local market and the needs of industry development, we are very keen to see China will continue to deepen reform of its medical system, accelerate introducing global innovative medicines and build a multilayer health security system, ensuring a more attractive and open market environment for foreign bio-pharmaceutical companies.

    |<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    久久午夜伦鲁片免费无码| 一本一道av中文字幕无码| 中文字字幕在线中文无码| 四虎影视无码永久免费| 欧美日韩国产中文高清视频| 亚洲成AV人片在线播放无码| 美丽姑娘免费观看在线观看中文版| 国产精品无码午夜福利| 中文字幕乱人伦| 最近免费2019中文字幕大全| 中文字字幕在线中文乱码不卡| 日韩国产成人无码av毛片| 亚洲精品无码午夜福利中文字幕| 91天日语中文字幕在线观看 | 日韩精品无码一区二区三区四区 | 国产精品无码免费专区午夜| 亚洲中文字幕无码日韩| 中文字幕精品一区二区日本| 最近2019中文免费字幕在线观看 | 国产无码网页在线观看| 人妻无码视频一区二区三区| 亚洲国产AV无码专区亚洲AV | 亚洲AV无码一区二区三区性色 | 色综合久久中文字幕综合网| а天堂8中文最新版在线官网| 亚洲乱亚洲乱少妇无码| 黑人无码精品又粗又大又长| 国产午夜无码精品免费看动漫 | 久久无码精品一区二区三区| 国产AV巨作情欲放纵无码| 无码国产乱人伦偷精品视频| 亚洲AV人无码激艳猛片| 亚洲AV无码久久| 人妻aⅴ无码一区二区三区| 无码午夜成人1000部免费视频| 亚洲乱亚洲乱妇无码麻豆| 亚洲成AV人片天堂网无码| 亚洲AV无码码潮喷在线观看| 无码人妻AⅤ一区二区三区 | 午夜成人无码福利免费视频| 性无码专区一色吊丝中文字幕|